Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05374551 · ClinicalTrials.gov registry record · NA
Causal Role of Brain Networks in Episodic Memory
A NA study, sponsored by Boston College.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT05374551: Completed NA study, sponsored by Boston College.
NCT05374551 is a NA study that has completed, run by Boston College. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05374551, a NA study, has completed, sponsored by Boston College.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The goal of this study is to understand the basic brain mechanisms supporting episodic memory in healthy young adults. Transcranial magnetic stimulation will be used to influence brain activity in regions thought to be important for episodic memory. Behavioral testing and MRI will be used to measure the effects of stimulation on memory and on changes in brain network interactions, allowing us to draw causal inferences regarding the role of specific brain regions in memory processes.
Primary Outcome
Participants will complete tasks where they encode and retrieve events. Episodic memory quality will be assessed as the accuracy with which they can recall scene details associated with each event.
Interventions
- OTHER Transcranial magnetic stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2023-10-06 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the finished NCT05374551 record still lists
NCT05374551 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Transcranial magnetic stimulation is the first listed.
NCT05374551 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05374551 about?
NCT05374551 is a clinical study titled "Causal Role of Brain Networks in Episodic Memory". The goal of this study is to understand the basic brain mechanisms supporting episodic memory in healthy young adults. Transcranial magnetic stimulation will be used to influence brain activity in regions thought to be important for episodic memory. Behavioral testing and MRI will be used to measure...
What is the current status of trial NCT05374551?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2023-10-06. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT05374551?
The interventions under investigation include: Transcranial magnetic stimulation (OTHER).
Who is sponsoring clinical trial NCT05374551?
This trial is sponsored by Boston College, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05374551's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI